Pacemaker upgrade could ease stiff heart failure
NCT ID NCT07598760
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a special pacemaker-like device called Moderato Plus in 20 people with high blood pressure and a type of heart failure where the heart pumps normally but is too stiff (HFpEF). The device delivers Cardiac Neuromodulation Therapy to help control blood pressure and improve heart function during rest and exercise. Participants will be followed for up to 12 months to see if the therapy is feasible and safe.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Moderato Plus device with Cardiac Neuromodulation Therapy (CNT)
What this could lead to
If successful, this could point toward a new device-based treatment to improve heart function and blood pressure control in people with HFpEF.
What could go wrong
This is a very small pilot study with only 20 participants, so results may not apply to everyone. The device is still experimental, and long-term benefits or risks are unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFPEF are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Georgian Medical Research Clinic Healthycore
Tbilisi, Georgia
-
Tbilisi Heart and Vascular Clinic
Tbilisi, Georgia